Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Int J Clin Rheumtol. 2012 Dec;7(6):651–659. doi: 10.2217/ijr.12.64

Table 4.

Hematologic findings and proteins

Hematologic findings Clinical correlation
Normocytic–microcytic
anemia
Prevalence of renal involvement, cutaneous vasculitis, peripheral
neuropathy
Presence of ANA, RF, cryoglobulinemia and hypocomplementemia
Lymphopenia Significantly associated at diagnosis with an increased risk of lymphoma
Monoclonal gammopathy Associated with EGMs and risk of lymphoproliferative disease
Polyclonal
hypergammaglobulinemia
Higher prevalence of extraglandular manifestations and B-cell lymphoma
Hypogammaglobulinemia Associated with lymphoproliferative syndromes, humoral
immunodeficiency
Erythrocyte sedimentation
rate (>50 mm/h)
Thyroiditis, renal disease, peripheral neuropathy, cutaneous vasculitis
Anti-SSB/La, RF, cryoglobulinemia and hypocomplementemia
B2 microglobulin Useful method for estimating the degree of lymphocytic infiltration
Possible evolution marker of lymphoproliferation
Soluble receptor IL-2 Possible evolution marker for lymphoma

ANA: Antinuclear antibodies; EGM: Extraglandular manifestation; RF: Rheumatoid factor.